Free Trial
→ Now I look stupid. Real stupid... (From Porter & Company) (Ad)

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Written by MarketBeat Staff
May 18, 2023

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Denali Therapeutics Right Now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover
20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Denali Therapeutics (DNLI)
4.1221 of 5 stars		$16.25+3.6%N/A-5.89Buy$37.57
Ultragenyx Pharmaceutical (RARE)
4.3242 of 5 stars		$37.98-0.3%N/A-5.99Moderate Buy$92.79
Sarepta Therapeutics (SRPT)
4.6691 of 5 stars		$61.51+1.8%N/A49.21Moderate Buy$158.70
Pfizer (PFE)
4.9929 of 5 stars		$23.04+0.5%7.47%16.34Moderate Buy$29.57
Exelixis (EXEL)
4.1902 of 5 stars		$38.44+2.7%N/A21.72Moderate Buy$37.59
Moderna (MRNA)
4.343 of 5 stars		$27.46+0.9%N/A-2.96Hold$58.70
United Therapeutics (UTHR)
4.8966 of 5 stars		$297.04+1.9%N/A13.05Moderate Buy$390.17
Biogen (BIIB)
4.7549 of 5 stars		$119.12+0.2%N/A10.65Hold$203.07
Sanofi (SNY)
3.7155 of 5 stars		$52.76+0.8%3.03%21.19Buy$63.33
Eli Lilly and Company (LLY)
4.9165 of 5 stars		$877.25-0.8%0.68%74.91Moderate Buy$1,000.32
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio
February 5, 2025

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Watch Video

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines